Ours Privacy Raises $15M in Series A Funding

Ours Privacy raised a $15M Series A led by Lightbank and Health Velocity Capital, with Rock Health, Lakehouse, TMV, Switch Ventures, Starfire Ventures, and GreyMatter participating as existing investors. The Houston healthcare data company announced the round on August 19, 2026, and said the capital will accelerate product investment and help it reach more enterprise healthcare organizations.

The financing matters because healthcare marketing has become a data-infrastructure problem with legal consequences. Providers still need to understand which campaigns lead patients to care, but the trackers and analytics tools borrowed from retail technology can create new paths for sensitive information to leave controlled systems. Ours Privacy is building a growth stack where privacy is part of the architecture instead of a cleanup task after data starts moving.

What Happened

The company described the Series A as multiple-times oversubscribed in its official funding announcement. Lightbank and Health Velocity Capital co-led the $15M round, while Rock Health, Lakehouse, TMV, Switch Ventures, Starfire Ventures, and GreyMatter returned as participants. Ours Privacy did not disclose a valuation, and the amount of its 2025 financing remains undisclosed, so a current total-funding figure cannot be stated responsibly.

Ours Privacy says the new capital will support a broader enterprise version of the bet its founders made in 2024. The platform serves more than 200 healthcare organizations and processes billions of data points each month, according to company-reported metrics. Those numbers are not independently audited in the announcement, but they show the scale investors are underwriting and the distance the business has traveled from an internal operating fix.

From Telehealth Constraint to Data Platform

Co-founders Jessica Holton, Adam Putterman, and Tyler Zey encountered the original problem while operating Ours Wellness, a telehealth company handling unusually sensitive information. As AdExchanger reported in its founder profile, removing common scripts and advertising pixels protected data but also made marketing performance harder to measure. Tyler Zey built a server-side approach that gave the team more control over what information could be sent to downstream tools.

That workaround became Ours Privacy, which launched commercially in 2024. Jessica Holton is now co-founder and CEO, Adam Putterman is co-founder and chief revenue officer, and Tyler Zey is co-founder and chief technology officer. Their advantage is not that they discovered healthcare privacy was complicated; it is that they had already tried to operate without the visibility ordinary growth teams take for granted.

Why This Matters

Healthcare organizations do not get to choose a simple version of modern marketing. They need analytics, attribution, consent, experimentation, advertising activation, and reliable patient journeys, but every additional vendor connection creates another place to inspect, govern, and defend. A fragmented stack can turn a useful campaign into a compliance and patient-trust problem before anyone notices which integration caused it.

Ours Privacy uses server-side connections to collect and stitch data, then gives teams control over what is filtered, de-identified, or permitted to reach tools such as Google Ads, Meta Ads, EHRs, scheduling systems, analytics services, and data warehouses. Its product now spans a customer data platform, consent and tag management, attribution, A/B testing, personalization, session replay, audience building, embedded media, translations, and automated web scanning. The company also reports signed business associate agreements, SOC 2 Type II status, U.S.-hosted infrastructure, and a policy against using customer data for AI training.

The Investor Logic

Lightbank partner Eric Ong said product quality and customer feedback drove the firm's decision, while Health Velocity Capital co-founder and managing partner Saurabh Bhansali emphasized the regulatory constraints built into healthcare from the start. Those views point to the same investment thesis from different angles. A generalist technology investor sees a broad product surface and customer pull, while a healthcare specialist sees a market where compliance requirements can make purpose-built infrastructure more durable.

The returning investor group also matters. Rock Health led a 2025 financing tied to Ours Privacy's launch of an integrated consent-management platform, with Switch Ventures, GreyMatter, and TMV participating. Their return suggests the company has moved beyond a narrow pixel-replacement product toward a fuller operating layer for healthcare growth teams.

Competitive and Regulatory Context

Ours Privacy is entering a market with credible alternatives. Freshpaint offers healthcare-focused data controls, RudderStack supports healthcare use cases through broader data infrastructure, and other healthcare marketing vendors are expanding into adjacent analytics and activation workflows. The competitive question is whether Ours Privacy can make a wide product suite dependable enough for enterprise buyers that measure software risk in regulatory exposure, security reviews, and patient trust.

The regulatory backdrop is also more nuanced than a simple claim that all website tracking violates HIPAA. Federal guidance, enforcement actions, court decisions, FTC authority, and state privacy laws create overlapping obligations that depend on what data is collected, where it appears, and how vendors handle it. Ours Privacy is selling technical control across that complexity, which is a stronger proposition than relying on one rule, one agency, or one interpretation to remain fixed.

What This Signals

The $15M Series A signals that healthcare marketing technology is moving closer to core infrastructure. Measurement, consent, experimentation, and data governance are converging because buyers cannot afford to manage them as disconnected tools that exchange sensitive information without a common control layer. Privacy becomes more useful when it improves the operating model instead of merely documenting restrictions.

Ours Privacy still has to prove that consolidation produces a platform enterprises can trust at scale. The company-reported customer base and new investor group give it capital and credibility, but execution now shifts toward product depth, implementation quality, and consistent performance across demanding healthcare environments. Congratulations to Jessica Holton, Adam Putterman, Tyler Zey, and the Ours Privacy team on funding an idea that healthcare operators have already been forced to understand: responsible growth begins with control over the data underneath it.